Lisa McBryar
Nurse Practitioner · Atlanta, GANPI 1205954021
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 512 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,518, more than ten times the $95 reported in 2021. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 512 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- AbbVie$916
- Otsuka America Pharmaceutical, Inc.$615
- Lundbeck LLC$474
- plus $3K from 16 others
What the payments were for
- Food & beverage$8,94999%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 87 | $1,673 |
| Johnson & Johnson | 54 | $1,253 |
| Alkermes, Inc. | 57 | $1,085 |
| AbbVie | 84 | $916 |
| Otsuka America Pharmaceutical, Inc. | 32 | $615 |
| Lundbeck LLC | 23 | $474 |
| Corium, LLC | 27 | $430 |
| Teva Pharmaceuticals USA, Inc. | 21 | $330 |
| Noven Therapeutics, LLC | 18 | $330 |
| Tris Pharma Inc | 17 | $278 |
| Ironshore Pharmaceuticals Inc. | 15 | $260 |
| Supernus Pharmaceuticals, Inc. | 15 | $246 |
| Axsome Therapeutics, Inc. | 9 | $236 |
| Vanda Pharmaceuticals Inc. | 12 | $221 |
| Neurocrine Biosciences, Inc. | 9 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $160 |
| Sunovion Pharmaceuticals Inc. | 12 | $116 |
| Neos Therapeutics, LP | 4 | $56 |
| Bausch Health US, LLC | 2 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$8,996 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 30 | $7,936 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $2,043 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 67 | $677 |
| Quetiapine Fumarate | 47 | $637 |
| Duloxetine Hcl | 14 | $501 |
| Hydroxyzine Hcl | 16 | $459 |
| Trazodone Hcl | 68 | $391 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $299 |
| Lamotrigine | 14 | $220 |
| Amitriptyline Hcl | 11 | $215 |
| Buspirone Hcl | 29 | $200 |
| Fluoxetine Hcl | 43 | $180 |
| Aripiprazole | 12 | $134 |
| Sertraline Hcl | 17 | $123 |
| Gabapentin | 14 | $120 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Atlanta
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Casey MillerAtlanta$41K
- Kathryn InanAtlanta$17K
- Colby DoepelAtlanta$16K
- Mark HebertAtlanta$15K
- Ashley BlackmonAtlanta$13K
- Alexia CovingtonAtlanta$13K
- Marissa TorresAtlanta$12K
- Hayley TurnerAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.